AP 1100

N/A

Report date: 2022/04/18 09:34:59

Base Information

Drug NameAP 1100
Drug Alias NameAP1100AP 1100AP-1100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsShock
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriel PharmaceuticalUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsShock

Other Information

ATC CodeN/A
Related LinksN/A